.avif)
Case studies
Proven impact across the healthcare innovation journey
Explore selected examples of how Newmarket Strategy helps healthcare, life sciences and organisations move through complex market challenges.
Shaping the national policy framework for technology adoption
A globally leading medical technology company had a transformative technology but no national policy framework to drive its adoption at scale. Newmarket Strategy designed and led a government affairs programme that took the technology from the periphery of national healthcare policy to the heart of Government's transformation agenda.
Securing a landmark strategic partnership with the UK government
We helped a major pharmaceutical company win a highly competitive landmark strategic partnership with the UK government to transform how a major disease is prevented, diagnosed and treated.
Orchestrating pan-European government affairs for the launch of a pioneering oncology medicine
We led the pan-European government affairs strategy for a US pharmaceutical company launching a pioneering oncology medicine, coordinating activity across multiple markets to support a coherent, well-governed European rollout.
Bringing together technical and strategic expertise to represent the full value of an innovative product in an underserved area
A global pharmaceutical company partnered with us to provide them a suite of market access activities to realise the full potential of a product with a novel mechanism of action
Informing early pricing strategy through an interactive economic modelling platform
The bespoke, user-friendly app we developed allowed our client to communicate their pricing potential to a wide stakeholder group, enabling them to make data-informed decisions about future evidence generation and launch sequencing.
Ideating an innovative deal structure
A pharmaceutical company approached Newmarket with a view to develop an innovative commercial arrangement that would give it an edge over its competition. The company was particularly keen to understand the different types of commercial archetypes available, and whether to pursue an asset-specific deal or a pipeline deal across its broader portfolio .